Longitudinal antibody repertoire in “mild” versus “severe” COVID-19 patients reveals immune markers associated with disease severity and resolution

Limited knowledge exists on immune markers associated with disease severity or recovery in patients with coronavirus disease 2019 (COVID-19). Here, we elucidated longitudinal evolution of SARS-CoV-2 antibody repertoire in patients with acute COVID-19. Differential kinetics was observed for immunoglo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravichandran, Supriya, Lee, Youri, Grubbs, Gabrielle, Coyle, Elizabeth M., Klenow, Laura, Akasaka, Osamu, Koga, Michiko, Adachi, Eisuke, Saito, Makoto, Nakachi, Ichiro, Ogura, Takayuki, Baba, Rie, Ito, Mutsumi, Kiso, Maki, Yasuhara, Atsuhiro, Yamada, Shinya, Sakai-Tagawa, Yuko, Iwatsuki-Horimoto, Kiyoko, Imai, Masaki, Yamayoshi, Seiya, Yotsuyanagi, Hiroshi, Kawaoka, Yoshihiro, Khurana, Surender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935365/
https://www.ncbi.nlm.nih.gov/pubmed/33674317
http://dx.doi.org/10.1126/sciadv.abf2467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935365/
https://www.ncbi.nlm.nih.gov/pubmed/33674317
http://dx.doi.org/10.1126/sciadv.abf2467

Ejemplares similares